Expression and characterization of mucins associated with the resistance to methotrexate of human colonic adenocarcinoma cell line HT29.
A series of experiments were conducted to study synthesis and secretion of mucin in mucus-secreting subpopulations of HT29 human colonic adenocarcinoma cells selected by resistance to methotrexate (MTX). Mucin was quantitated by [3H]glucosamine labeling and chromatography on Sepharose CL-4B. The mucinous nature of the labeled high molecular weight glycoprotein was verified by alkaline borohydride treatment, cesium chloride density gradient ultracentrifugation, and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The results of these experiments demonstrated that MTX-treated cells have increased amounts of mucin in medium, cytosol, and membrane fractions. This was associated with the increase in the activities of polypeptidyl-N-acetylgalactosaminyltransferase and beta-1,3-galactosyltransferase compared to control cells. DEAE-Sephacel chromatography of [3H]glucosamine-labeled high molecular weight glycoproteins suggest that MTX-treated cells are less acidic compared to controls. Using complementary DNA probes for two distinct human intestinal mucins (MUC2 and MUC3) and one mammary mucin (MUC1), it was found that MTX-treated cells expressed more mucin messages compared to untreated cells. These results were consistent with immunoblots using anti-MRP (MUC2 repeat peptide), anti-M3P (MUC3 repeat peptide), 139H2 (MUC1 peptide), anti-T (peanut lectin), anti-Tn (91S8), and anti-sialosyl Tn (JT10e) antibodies. These data indicate that MTX-resistant HT29 cells show enhanced secretion and synthesis of mucin as well as expression of MUC1-, MUC2-, and MUC3-related mucin polypeptide epitopes.
Dahiya
R
R
Gastrointestinal Research Laboratory, VA Medical Center, San Francisco, California 94121.
Lesuffleur
T
T
Kwak
K S
KS
Byrd
J C
JC
Barbat
A
A
Zweibaum
A
A
Kim
Y S
YS
D002454:Cell Differentiation; D003110:Colonic Neoplasms / Q000378:metabolism* / Q000473:pathology; D004351:Drug Resistance; D005455:Fluorescent Antibody Technique; D015870:Gene Expression; D016695:Glycosyltransferases / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D008727:Methotrexate / Q000494:pharmacology*; D009077:Mucins / Q000235:genetics / Q000378:metabolism*; D012333:RNA, Messenger / Q000235:genetics; D012334:RNA, Neoplasm / Q000235:genetics; D012794:Sialic Acids / Q000378:metabolism; D014407:Tumor Cells, Cultured
D009077:Mucins; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D012794:Sialic Acids; D016695:Glycosyltransferases; D008727:Methotrexate